Coya Therapeutics Announces Publication Of Potential Novel Blood Biomarker Data In Amyotrophic Lateral Sclerosis Patients That Accurately Reflect Therapeutic Responses When Treated with Regulatory T Cell Enhancing Therapies
Pathological hallmarks of ALS are characterized by alterations in inflammation and oxidative stress, with oxidative stress playing a critical role in neuronal damage.
4-hydroxy-2-nonenal (4-HNE) is a key mediator of